# Universal Technical Institute, Inc. (UTI)

> Source: Nexqual · https://nexqual.com/UTI · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Universal Technical Institute, Inc. (UTI), nexqual.com/UTI" · informational, not investment advice.

**Price:** USD 21.66 (+4.13% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 20.8 · day 20.14–21.69 · 52w 18.02–51.34 · market cap $1.19B · NYQ

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $884M, net income $34.3M (3.9% margin), free cash flow -$22.9M (SEC filings).
- Valuation: P/E 34.8x (avg 23.9x at the last 3 fiscal year-ends), EV/EBITDA 14.6x, net cash $10.1M.
- 1 of 80 tracked superinvestors hold UTI (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 5 Form 4 filings, $129M; 5 not under a Rule 10b5-1 plan ($129M); 1 by opportunistic insiders (1 outside 10b5-1 plans), 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Insider open-market purchases, last ~7 months: 6 Form 4 filings, $335K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Buy (mean 1.83 on a 1–5 scale) (6 analysts), mean target USD 38.83 (range 30–48).
- Total return with dividends: 1Y -36.2% vs S&P 500 +14.9%; 5Y +222.3% vs S&P 500 +80.3%.
- Next earnings: 2026-11-18, EPS estimate USD 0.33, revenue estimate $235M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $335M | $419M | $607M | $733M | $836M | $884M |
| Operating income | $14.9M | $22.4M | $21.4M | $58.9M | $83.5M | $44.3M |
| Net income | $14.6M | $25.8M | $12.3M | $42.0M | $63.0M | $34.3M |
| EPS (diluted) | $0.17 | $0.38 | $0.13 | $0.75 | $1.13 | — |
| Free cash flow | -$6.1M | -$33.4M | -$7.5M | $61.6M | $55.4M | -$22.9M |
| Operating margin | 4.5% | 5.3% | 3.5% | 8.0% | 10.0% | 5.0% |
| Net margin | 4.4% | 6.2% | 2.0% | 5.7% | 7.5% | 3.9% |
| Revenue growth | +11.4% | +25.0% | +45.0% | +20.6% | +14.0% | — |
| Cash + short-term investments | $134M | $66.5M | $152M | $162M | $169M | — |
| Total debt | $30.7M | $67.5M | $162M | $126M | $87.1M | — |
Fiscal years end Sep. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 34.8x · P/S 1.4x · EV/EBITDA 14.6x · EV/Sales 1.3x · P/B 3.5x · FCF yield -1.92% · Earnings yield 2.87% · Net cash $10.1M · EV $1.18B
P/E at fiscal year-ends: Sep 2025 28.7x, Sep 2024 19.7x, Sep 2023 23.4x.

## Superinvestors (SEC 13F-HR, Q2 2026)
1 of 80 tracked investors hold UTI. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.04% | $24.4M | Added +20.8% |

## Insider sales (SEC Form 4, open-market, last ~7 months)
0 of 5 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-06-29 | Grant Jerome Alan | Chief Executive Officer | 94,500 | $3.9M | 22% | No | Too little history (no open-market trades in 2023) |
| 2026-06-22 | Prehn Kevin | Concorde Division President | 4,545 | $182K | 14.4% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-06-08 | Coliseum Capital Management, Llc | Director | 3,000,000 | $124M | 75.5% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-06-05 | Kline Christine | Senior Vice President and CAO | 3,500 | $155K | 7.5% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-05-11 | Srere Linda J | Director | 15,000 | $549K | 10.5% | No | Too little history (no open-market trades in 2023 or 2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

## Insider purchases (SEC Form 4, open-market, last ~7 months)
6 purchases, $335K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-09-28 | Devincenzi Robert Thomas | Director | 1,000 | $20K | 19.68 | Too little history (no open-market trades in 2023) |
| 2026-09-21 | Devincenzi Robert Thomas | Director | 1,000 | $20K | 19.83 | Too little history (no open-market trades in 2023) |
| 2026-08-27 | Devincenzi Robert Thomas | Director | 1,000 | $22K | 21.8 | Too little history (no open-market trades in 2023) |
| 2026-08-25 | Devincenzi Robert Thomas | Director | 1,000 | $22K | 21.77 | Too little history (no open-market trades in 2023) |
| 2026-08-12 | Devincenzi Robert Thomas | Director | 1,000 | $26K | 25.95 | Too little history (no open-market trades in 2023) |
| 2026-08-10 | Devincenzi Robert Thomas | Director | 8,000 | $226K | 28.21 | Too little history (no open-market trades in 2023) |

## Analysts
Consensus Buy (mean 1.83 on a 1–5 scale), 6 analysts; mean target USD 38.83 (low 30, high 48).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-06 | Truist Securities | Target lowered | Buy | $47 → $38 |
| 2026-08-06 | B. Riley Securities | Target lowered | Buy | $49 → $48 |
| 2026-08-06 | Rosenblatt | Maintained | Buy | $45 |
| 2026-06-29 | Truist Securities | Target raised | Buy | $40 → $47 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | -36.2% | +222.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -36.3% | +26.3% |
| Volatility (annualized) | 72.5% | 50.6% |
| Max drawdown | -63.9% (Jul 2026→Sep 2026) | -60.0% (Jul 2026→Sep 2026) |

## Peers (Education & Training Services)
AFYA (Afya Limited) USD 14.91 +0.07% · COUR (Coursera, Inc.) USD 5.07 +2.01% · APEI (American Public Education, Inc.) USD 48.86 +2.26% · PXED (Phoenix Education Partners, Inc) USD 24.57 +3.85% · STRA (Strategic Education, Inc.) USD 81.59 +2.56% · LINC (Lincoln Educational Services Co) USD 21.96 +3.34%

## More
Full page: https://nexqual.com/UTI · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Revenue by business segment (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY | Operating income | Op. margin |
|---|---|---|---|---|---|
| UTI | $138.0M | 63.0% | +5.0% | $5.8M | 4.2% |
| Concorde | $80.9M | 37.0% | +11.1% | $3.2M | 3.9% |
| Corporate costs (not allocated) | — | — | — | -$5.7M | — |
| Total revenue | $218.9M | 100% | — | $3.2M | 1.5% |

## Company outlook (8-K filed 2026-08-05)

- "Previous Updated FY 2026 FY 2026 ($ in millions, except EPS) Guidance Guidance New student starts 31,500 - 33,000 31,900 - 32,300 Revenue $905 - 915 $893 - 900 Net Income $40 - 45 $32 - 36 Diluted EPS $0.71 - 0.80 $0.57 - 0.64 Adjusted EBITDA (1) $114 - 119 $100 - 103 Adjusted free cash flow (1)(2) $20 - 25 $(20) - 0 (1) See the "Use of Non-GAAP Financial Information" below."
- "(2) For FY 2026, assumes approximately $110 million of cash capex, including investments for new campus launches and program expansions, and maintenance capex."

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.33 | $0.52 | -37.3% | $235.0M | 6 |
| Next quarter (ends 2026-12-31) | $0.16 | $0.18 | -11.2% | $234.9M | 5 |
| Current fiscal year (ends 2026-09-30) | $0.60 | $0.78 | -22.3% | $896.2M | 6 |
| Next fiscal year (ends 2027-09-30) | $0.73 | $0.85 | -13.7% | $971.9M | 6 |

## Options: expected move (Cboe, 15-min delayed)

Expected move by 2026-11-20 (includes earnings 2026-11-18): ±15.2%; last 8 reports averaged ±15.2%.

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 28 | 65.3% | ±15.2% |
| 2026-12-18 | 56 | 61.8% | ±20.0% |
| 2027-01-15 | 84 | 58.7% | ±23.1% |
| 2027-04-16 | 175 | 59.4% | ±33.2% |